Expert Opinion on Investigational Drugs, Volume 33, Issue 7 (2024)

Browse this journal

Expert Opinion on Investigational Drugs, Volume 33, Issue 7 (2024)

See all volumes and issues
Volume 33, 2024 Vol 32, 2023 Vol 31, 2022 Vol 30, 2021 Vol 29, 2020 Vol 28, 2019 Vol 27, 2018 Vol 26, 2017 Vol 25, 2016 Vol 24, 2015 Vol 23, 2014 Vol 22, 2013 Vol 21, 2012 Vol 20, 2011 Vol 19, 2010 Vol 18, 2009 Vol 17, 2008 Vol 16, 2007 Vol 15, 2006 Vol 14, 2005 Vol 13, 2004 Vol 12, 2003 Vol 11, 2002 Vol 10, 2001 Vol 9, 2000 Vol 8, 1999 Vol 7, 1998 Vol 6, 1997 Vol 5, 1996 Vol 4, 1995 Vol 3, 1994
Download citations Download PDFs Download issue

Editorial

Editorial
Will new investigational drugs change the way we treat Charcot-Marie-Tooth disease?
Amedeo De Grado, Chiara Pisciotta, Paola Saveri & Davide Pareyson
Pages: 653-656
Published online: 08 May 2024
First Page PreviewforWill new investigational drugs change the way we treat Charcot-Marie-Tooth disease? | Full Text | References | PDF (1.3 MB) | EPUB
  • 448 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Lepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular disease
P. Mihika S. Fernando, Amanda J. Hooper & John R. Burnett
Pages: 657-659
Published online: 08 May 2024
First Page PreviewforLepodisiran, an siRNA targeting lipoprotein(a) for the potential future treatment of cardiovascular disease | Full Text | References | PDF (167.2 KB) | EPUB
  • 719 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Special Report

Report
Investigational bispecific antibodies for the treatment of rheumatoid arthritis
Aliki I. Venetsanopoulou, Paraskevi V. Voulgari & Alexandros A. Drosos
Pages: 661-670
Published online: 08 May 2024
AbstractforInvestigational bispecific antibodies for the treatment of rheumatoid arthritis | Full Text | References | PDF (2.4 MB) | EPUB
  • 94 Views
  • 0 CrossRef citations
  • 0Altmetric
Report
Investigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development
Luca Iorio, Roberto Padoan, Milena Bond & Christian Dejaco
Pages: 671-676
Published online: 16 Jun 2024
AbstractforInvestigational agents for polymyalgia rheumatica treatment: assessing the critical needs for future development | Full Text | References | PDF (222.4 KB) | EPUB
  • 120 Views
  • 0 CrossRef citations
  • 0Altmetric

Review

Review Article
Therapies in preclinical and in early clinical development for the treatment of urinary tract infections: from pathogens to therapies
Virginia Fuochi, Salvatore Furnari, Laura Trovato, Maddalena Calvo & Pio Maria Furneri
Pages: 677-698
Published online: 09 May 2024
AbstractforTherapies in preclinical and in early clinical development for the treatment of urinary tract infections: from pathogens to therapies | Full Text | References | PDF (3.1 MB) | EPUB
  • 33 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Therapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases
Nadia Martinez Naya, Jazmin Kelly, Austin Hogwood, Antonio Abbate & Stefano Toldo
Pages: 699-712
Published online: 09 May 2024
AbstractforTherapeutic potential of cannabidiol (CBD) in the treatment of cardiovascular diseases | Full Text | References | PDF (3.5 MB) | EPUB
  • 99 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
Clinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration
Shogo Hashimoto, Narihito Nagoshi, Masaya Nakamura & Hideyuki Okano
Pages: 713-720
Published online: 29 May 2024
AbstractforClinical application and potential pluripotent effects of hepatocyte growth factor in spinal cord injury regeneration | Full Text | References | PDF (2.8 MB) | EPUB | Supplemental
  • 38 Views
  • 0 CrossRef citations
  • 0Altmetric
Review Article
The role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy
Ava Aghakhani, Parmida Sadat Pezeshki & Nima Rezaei
Pages: 721-740
Published online: 30 May 2024
AbstractforThe role of extracellular vesicles in immune cell exhaustion and resistance to immunotherapy | Full Text | References | PDF (2.7 MB) | EPUB
  • 93 Views
  • 0 CrossRef citations
  • 0Altmetric

Original Research

Article
Safety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study
Ling Yang, Yuan Fang, Yuan Luo, Meng Fu, Kai Shen & Zhu Luo
Pages: 741-752
Published online: 03 Jun 2024
AbstractforSafety, pharmacokinetics and pharmacodynamics of SHR-1703, an innovative long-acting anti-interleukin-5 monoclonal antibody, in healthy subjects: a randomized, double-blind, dose-escalation, placebo-controlled phase I study | Full Text | References | PDF (2.6 MB) | EPUB
  • 47 Views
  • 0 CrossRef citations
  • 0Altmetric

Explore articles